{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:22Z","timestamp":1789628542063,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) is a prevalent malignant neoplasm characterized by high incidence and mortality rates. Currently, the role of microRNAs (miRNAs) in CRC is increasingly recognized. In this study, we aim to investigate the prognostic value of miR-363-5p and its associated molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 156 paired samples were collected from patients with CRC. The levels of miR-363-5p in the samples were detected by RT-qPCR. KM curves and multivariable Cox regression models evaluated the prognostic value of miR-363-5p. Flow cytometry, CCK-8 assay and Transwell assay examined the effects of miR-363-5p on cellular malignant phenotypes. Dual-luciferase reporter assays validated the targeting relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression level of miR-363-5p was declined in CRC, and patients with TNM stage III\u2009+\u2009IV exhibited lower miR-363-5p expression compared to those with TNM stage I\u2009+\u2009II. Furthermore, individuals with low miR-363-5p expression demonstrated shorter overall survival than those with high expression, and miR-363-5p was confirmed as an independent protective factor for CRC. In vitro, miR-363-5p suppressed cellular malignant phenotypes, primarily manifested by miR-363-5p mimic promoting apoptosis while inhibiting proliferation, migration and invasion. Mechanistically, we identified MEIS3 as a direct target of miR-363-5p, and rescue experiments confirmed that MEIS3 overexpression attenuated the tumor-suppressive effects of miR-363-5p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Downregulated miR-363-5p were involved in CRC progression and associated with poor patient prognosis. Mechanistically, upregulated miR-363-5p suppressed the malignant cellular phenotype by negatively regulating MEIS3, thereby inhibiting the progression of CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00716-4","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:06:23Z","timestamp":1785758783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The prognostic value of miR-363-5p in colorectal cancer and its associated molecular mechanisms"],"prefix":"10.1186","volume":"163","author":[{"given":"Feng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanguo","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"40","key":"716_CR1","doi-asserted-by":"publisher","first-page":"e44759","DOI":"10.1097\/md.0000000000044759","volume":"104","author":"AS Talpur","year":"2025","unstructured":"Talpur AS, Atasi A, Knowles CG, Hafizyar F, Basit AK, Showkat S, et al. Colorectal cancer screening methods: A systematic review. Medicine. 2025;104(40):e44759. https:\/\/doi.org\/10.1097\/md.0000000000044759.","journal-title":"Medicine"},{"issue":"1","key":"716_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13668-025-00701-9","volume":"14","author":"S Brandolino","year":"2025","unstructured":"Brandolino S, Franzago M, Murmura G, Ricci F, Gatta V, Stuppia L, et al. Nutrition, Environment, and Genetics in Colorectal Cancer. Epigenetics and Possible Future Perspective. Curr Nutr Rep. 2025;14(1):111. https:\/\/doi.org\/10.1007\/s13668-025-00701-9.","journal-title":"Curr Nutr Rep"},{"key":"716_CR3","doi-asserted-by":"publisher","first-page":"1597847","DOI":"10.3389\/fonc.2025.1597847","volume":"15","author":"S Chang","year":"2025","unstructured":"Chang S, Chang Y, Li F, Xu Z, Han X, Liu Y, et al. Global, regional, national burden of colorectal cancer from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021. Front Oncol. 2025;15:1597847. https:\/\/doi.org\/10.3389\/fonc.2025.1597847.","journal-title":"Front Oncol"},{"key":"716_CR4","doi-asserted-by":"publisher","unstructured":"Kowalska MK, El-Mallul A, Luboja\u0144ska JE, Hudecka W, Or\u0142owska SM, Luboja\u0144ski PJ, et al. Molecular Basis, Diagnostic Approaches, and Therapeutic Strategies in Colorectal Cancer-Comprehensive Review. Int J Mol Sci. 2025;26(19). https:\/\/doi.org\/10.3390\/ijms26199520.","DOI":"10.3390\/ijms26199520"},{"key":"716_CR5","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2147\/ott.S551204","volume":"18","author":"J Li","year":"2025","unstructured":"Li J, Fu T, Wen Z, Liang J, Qiu Y, Li K, et al. Advances in the Use of Immune Checkpoint Inhibitors for Colorectal Cancer Treatment. OncoTargets therapy. 2025;18:1159\u201368. https:\/\/doi.org\/10.2147\/ott.S551204.","journal-title":"OncoTargets therapy"},{"issue":"3","key":"716_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. Cancer J Clin. 2023;73(3):233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"Cancer J Clin"},{"issue":"1","key":"716_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12916-025-04311-8","volume":"23","author":"E Bouras","year":"2025","unstructured":"Bouras E, Papagiannopoulos CK, Mustafa R, Sobieski D, Schmit SL, Wu AH, et al. Investigating the relationship of plasma microRNAs and colorectal cancer risk using genetic evidence. BMC Med. 2025;23(1):532. https:\/\/doi.org\/10.1186\/s12916-025-04311-8.","journal-title":"BMC Med"},{"issue":"1","key":"716_CR8","doi-asserted-by":"publisher","first-page":"33421","DOI":"10.1038\/s41598-025-18832-y","volume":"15","author":"H Xu","year":"2025","unstructured":"Xu H, Xie X, Han J, Zhang C. miR-340 reverses chemotherapy resistance in colon cancer via the PDCD4\/WNT\/\u03b2-catenin signalling pathway. Sci Rep. 2025;15(1):33421. https:\/\/doi.org\/10.1038\/s41598-025-18832-y.","journal-title":"Sci Rep"},{"key":"716_CR9","doi-asserted-by":"publisher","unstructured":"Piccinno E, Aloisio M, Scalavino V, Russo F, Giannelli G, Guido D, et al. Exploring miRNA Research in Colorectal Cancer: Insights from a Bibliometric Analysis. Pharmaceutics. 2025;17(8). https:\/\/doi.org\/10.3390\/pharmaceutics17081084.","DOI":"10.3390\/pharmaceutics17081084"},{"key":"716_CR10","doi-asserted-by":"publisher","unstructured":"Barbolov M, Slavova S, Nedeva N, Ivanov K, Kolev N, Komosinska-Vassev K, et al. Dysregulated miRNAs Targeting Adiponectin Signaling in Colorectal Cancer. Int J Mol Sci. 2025;26(15). https:\/\/doi.org\/10.3390\/ijms26157196.","DOI":"10.3390\/ijms26157196"},{"issue":"7","key":"716_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/0109298665305114240718072029","volume":"31","author":"S Tian","year":"2024","unstructured":"Tian S, Chen M, Jing W, Meng Q, Wu J. miR-1204 Positioning in 8q24.21 Involved in the Tumorigenesis of Colorectal Cancer by Targeting MASPIN. Protein Pept Lett. 2024;31(7):544\u201358. https:\/\/doi.org\/10.2174\/0109298665305114240718072029.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"716_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/0109298665256238231120093150","volume":"31","author":"M Wu","year":"2024","unstructured":"Wu M, Wu X, Han J. KIF20A Promotes CRC Progression and the Warburg Effect through the C-Myc\/HIF-1\u03b1 Axis. Protein Pept Lett. 2024;31(2):107\u201315. https:\/\/doi.org\/10.2174\/0109298665256238231120093150.","journal-title":"Protein Pept Lett"},{"key":"716_CR13","doi-asserted-by":"publisher","first-page":"e18761429283717","DOI":"10.2174\/0118761429283717231222104730","volume":"17","author":"M Li","year":"2024","unstructured":"Li M, Fan J, Hu M, Xu J, He Z, Zeng J. Quercetin Enhances 5-fluorouracil Sensitivity by Regulating the Autophagic Flux and Inducing Drp-1 Mediated Mitochondrial Fragmentation in Colorectal Cancer Cells. Curr Mol Pharmacol. 2024;17:e18761429283717. https:\/\/doi.org\/10.2174\/0118761429283717231222104730.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"716_CR14","doi-asserted-by":"publisher","first-page":"114697","DOI":"10.1016\/j.yexcr.2025.114697","volume":"451","author":"C Ke","year":"2025","unstructured":"Ke C, Wang P, Chen B, Cheng X, Zhang X, Xia R, et al. Upregulation of Linc00960 promotes colorectal cancer cell proliferation by regulating hsa-miR-107\/CDK6 axis. Exp Cell Res. 2025;451(1):114697. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114697.","journal-title":"Exp Cell Res"},{"issue":"6","key":"716_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X, et al. Circular RNA hsa_circ_0005939 Regulates UHRF1BP1L Expression by Targeting miR-4693-3p to Promote Colorectal Cancer Progression. Protein Pept Lett. 2024;31(6):437\u201346. https:\/\/doi.org\/10.2174\/0109298665297110240611115010.","journal-title":"Protein Pept Lett"},{"key":"716_CR16","doi-asserted-by":"publisher","unstructured":"Cheng Q, Fu H. The role of miR-1303 in colon cancer and its possible molecular mechanism based on bioinformatics. Nucleosides Nucleotides Nucleic Acids. 2025;1\u201316. https:\/\/doi.org\/10.1080\/15257770.2025.2560352.","DOI":"10.1080\/15257770.2025.2560352"},{"issue":"1","key":"716_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.14712\/fb2025071010018","volume":"71","author":"P Lin","year":"2025","unstructured":"Lin P, Qin X, Yi C, Jiang M, Yi L, Liang Y. Clinical Value and Regulatory Mechanism of miR-767-5p in Colorectal Cancer. Folia Biol. 2025;71(1):18\u201328. https:\/\/doi.org\/10.14712\/fb2025071010018.","journal-title":"Folia Biol"},{"issue":"10","key":"716_CR18","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.18632\/aging.204566","volume":"15","author":"J Yao","year":"2023","unstructured":"Yao J, Liu X, lncRNA. PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD. Aging. 2023;15(10):4071\u201383. https:\/\/doi.org\/10.18632\/aging.204566.","journal-title":"Aging"},{"issue":"3","key":"716_CR19","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1080\/21655979.2021.2018972","volume":"13","author":"Q Guo","year":"2022","unstructured":"Guo Q, Dong L, Zhang C, Liu D, Peng P. MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer. Bioengineered. 2022;13(3):5357\u201372. https:\/\/doi.org\/10.1080\/21655979.2021.2018972.","journal-title":"Bioengineered"},{"issue":"9","key":"716_CR20","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.4251\/wjgo.v15.i9.1556","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bai SK, Zhang T, Liao CG. MicroRNA-363-3p inhibits colorectal cancer progression by targeting interferon-induced transmembrane protein 1. World J Gastrointest Oncol. 2023;15(9):1556\u201366. https:\/\/doi.org\/10.4251\/wjgo.v15.i9.1556.","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"716_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s13577-025-01266-z","volume":"38","author":"C Mao","year":"2025","unstructured":"Mao C, Chai X, He H, Zhu J, Li J, Ma H, et al. Palmatine inhibits colorectal cancer proliferation and metastasis by regulating miR-363-3p\/AURKA axis. Hum Cell. 2025;38(5):138. https:\/\/doi.org\/10.1007\/s13577-025-01266-z.","journal-title":"Hum Cell"},{"key":"716_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2017.12.026","volume":"645","author":"G Chen","year":"2018","unstructured":"Chen G, Sun W, Hua X, Zeng W, Yang L. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p\/S100A1 pathway. Gene. 2018;645:76\u201384. https:\/\/doi.org\/10.1016\/j.gene.2017.12.026.","journal-title":"Gene"},{"issue":"5","key":"716_CR23","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.3892\/ol.2018.9384","volume":"16","author":"G Ying","year":"2018","unstructured":"Ying G, Wu R, Xia M, Fei X, He QE, Zha C, et al. Identification of eight key miRNAs associated with renal cell carcinoma: A meta-analysis. Oncol Lett. 2018;16(5):5847\u201355. https:\/\/doi.org\/10.3892\/ol.2018.9384.","journal-title":"Oncol Lett"},{"issue":"2","key":"716_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3892\/etm.2020.8738","volume":"20","author":"C Hou","year":"2020","unstructured":"Hou C, Wang X, Du B, lncRNA. MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p. Experimental therapeutic Med. 2020;20(2):978\u201384. https:\/\/doi.org\/10.3892\/etm.2020.8738.","journal-title":"Experimental therapeutic Med"},{"issue":"6","key":"716_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"Cancer J Clin"},{"issue":"7","key":"716_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325(7):669\u201385. https:\/\/doi.org\/10.1001\/jama.2021.0106.","journal-title":"JAMA"},{"issue":"5","key":"716_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.31661\/jbpe.v0i0.2501-1874","volume":"15","author":"SN Mousavikia","year":"2025","unstructured":"Mousavikia SN, Bahreyni-Toossi MMM, Aghaee-Bakhtiari MT, Azimian SH. Investigating miR-16-5p: The Tumor Suppressor That Influences Cell Cycle Genes in Colorectal Cancer. J biomedical Phys Eng. 2025;15(5):451\u20138. https:\/\/doi.org\/10.31661\/jbpe.v0i0.2501-1874.","journal-title":"J biomedical Phys Eng"},{"key":"716_CR28","doi-asserted-by":"publisher","unstructured":"Huang J, He Q, Wang J, Zhai C. Prognostic value of miR-21 in colorectal cancer, pancreatic ductal adenocarcinoma, and esophageal squamous cell carcinoma: updated systematic review and meta-analysis. Oncologist. 2025;30(10). https:\/\/doi.org\/10.1093\/oncolo\/oyaf309.","DOI":"10.1093\/oncolo\/oyaf309"},{"key":"716_CR29","doi-asserted-by":"publisher","unstructured":"Piccinno E, Scalavino V, Labarile N, Bianco G, Armentano R, Giannelli G, et al. miR-195-5p Suppresses KRT80 Expression Inducing Cell Cycle Arrest in Colon Cancer. Cancers. 2025;17(13). https:\/\/doi.org\/10.3390\/cancers17132183.","DOI":"10.3390\/cancers17132183"},{"issue":"4","key":"716_CR30","first-page":"481","volume":"24","author":"C Zhang","year":"2025","unstructured":"Zhang C, Yi S, Cao X, Wang J. Modulating Colorectal Cancer Cell Propagation and Immune Evasion by miRNA-148a-3p via KLF4. Iran J Allergy Asthma Immunol. 2025;24(4):481\u201397.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"2","key":"716_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.11817\/j.issn.1672-7347.2025.240243","volume":"50","author":"H Zhou","year":"2025","unstructured":"Zhou H, Wu M, Zhu S, Zhang Y. MiR-224-5p regulates chemoresistance in colorectal cancer via Bcl-2-mediated autophagy. Zhong nan da xue xue bao Yi xue ban = J Cent South Univ Med Sci. 2025;50(2):190\u2013203. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2025.240243.","journal-title":"Zhong nan da xue xue bao Yi xue ban = J Cent South Univ Med Sci"},{"issue":"9","key":"716_CR32","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/1878-0261.13029","volume":"15","author":"X Wang","year":"2021","unstructured":"Wang X, Qian T, Bao S, Zhao H, Chen H, Xing Z, et al. Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer. Mol Oncol. 2021;15(9):2466\u201379. https:\/\/doi.org\/10.1002\/1878-0261.13029.","journal-title":"Mol Oncol"},{"issue":"1","key":"716_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-8722-6-87","volume":"6","author":"A Costa","year":"2013","unstructured":"Costa A, Afonso J, Os\u00f3rio C, Gomes AL, Caiado F, Valente J, et al. miR-363-5p regulates endothelial cell properties and their communication with hematopoietic precursor cells. J Hematol Oncol. 2013;6(1):87. https:\/\/doi.org\/10.1186\/1756-8722-6-87.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"716_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/01616412.2024.2438613","volume":"47","author":"H Wu","year":"2025","unstructured":"Wu H, Zhu L, Geng X, Guo X, Wang T, Xu J, et al. miR-363-5p protects from neuropathic pain in chronic constriction injury (CCI) rat models and regulates Schwann cell injury via negatively modulating SERPING1. Neurol Res. 2025;47(1):35\u201343. https:\/\/doi.org\/10.1080\/01616412.2024.2438613.","journal-title":"Neurol Res"},{"issue":"14","key":"716_CR35","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1158\/0008-5472.Can-24-3841","volume":"85","author":"M Eriksen Gjerstad","year":"2025","unstructured":"Eriksen Gjerstad M, Aehnlich P, Gelebart P, Mc Cormack E. AXL Tyrosine Kinases: A Growing Isoform Family That Promotes Cancer Pathogenesis. Cancer Res. 2025;85(14):2561\u201373. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-3841.","journal-title":"Cancer Res"},{"key":"716_CR36","doi-asserted-by":"publisher","first-page":"556004","DOI":"10.3389\/fcell.2020.556004","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Pan Q, Shao Z. Tumor-Suppressive Role of microRNA-202-3p in Hepatocellular Carcinoma Through the KDM3A\/HOXA1\/MEIS3 Pathway. Front cell Dev biology. 2020;8:556004. https:\/\/doi.org\/10.3389\/fcell.2020.556004.","journal-title":"Front cell Dev biology"},{"issue":"Pt A","key":"716_CR37","doi-asserted-by":"publisher","first-page":"107071","DOI":"10.1016\/j.intimp.2020.107071","volume":"89","author":"L Peng","year":"2020","unstructured":"Peng L, Chen Y, Ou Q, Wang X, Tang N. LncRNA MIAT correlates with immune infiltrates and drug reactions in hepatocellular carcinoma. Int Immunopharmacol. 2020;89(Pt A):107071. https:\/\/doi.org\/10.1016\/j.intimp.2020.107071.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"716_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10428194.2023.2275532","volume":"65","author":"N Meri\u00e7","year":"2024","unstructured":"Meri\u00e7 N, Albayrak E, G\u00fclba\u015f Z, Kocaba\u015f F. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. Leuk Lymphoma. 2024;65(2):187\u201398. https:\/\/doi.org\/10.1080\/10428194.2023.2275532.","journal-title":"Leuk Lymphoma"},{"key":"716_CR39","doi-asserted-by":"publisher","unstructured":"Ma J, Li H, Gao Q, Zhang W, Zhu C, Chen J et al. High MEIS3 Expression Indicates a Poor Prognosis for Patients with Stage II\/III Colorectal Cancer. Frontiers in bioscience (Landmark edition). 2023;28(12):338. https:\/\/doi.org\/10.31083\/j.fbl2812338.","DOI":"10.31083\/j.fbl2812338"},{"key":"716_CR40","doi-asserted-by":"publisher","first-page":"2046248","DOI":"10.1155\/2020\/2046248","volume":"2020","author":"P Cai","year":"2020","unstructured":"Cai P, Xie Y, Dong M, Zhu Q. Inhibition of MEIS3 Generates Cetuximab Resistance through c-Met and Akt. Biomed Res Int. 2020;2020:2046248. https:\/\/doi.org\/10.1155\/2020\/2046248.","journal-title":"Biomed Res Int"},{"key":"716_CR41","doi-asserted-by":"publisher","unstructured":"Chen Y, Jia H, Zhang X, Zhao H, Xiao Y, Li N, et al. Disruption of GPSM1\/CSF1 signaling reprograms tumor-associated macrophages to overcome anti-PD-1 resistance in colorectal cancer. J Immunother Cancer. 2025;13(2). https:\/\/doi.org\/10.1136\/jitc-2024-010826.","DOI":"10.1136\/jitc-2024-010826"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00716-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:07:42Z","timestamp":1789625262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00716-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00716-4","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"97"}}